Features

Antibacterials up the ante

22/09/2020
Antibacterials up the ante

To be clear from the start, none of the new finishes seeking to reduce viral activity can kill or cure covid-19. Covid-19 is the disease, not its agent, which is the novel coronavirus known as SARS-CoV-2. In the US a product cannot even profess to be ‘antiviral’, and the wording favoured in the EU is ‘viral-reducing’. This is the narrow framework within which companies need to navigate as they seek to respond to the demand for products offering consumers reassurance in these uncertain times.

To continue reading this story, please sign in or register.